Bevacizumab,Durvalumab,Olaparib,Carboplatin,Paclitaxel
AstraZeneca,roche,Merck
['ovarian', 'gyn', 'brca', 'imfinzi', 'duo-o', 'brca p', 'astrazeneca']
a role for immuno-oncology for #ovariancancer at last? s duo-o #clinicaltrial suggests that excluding #brca positive patients could be the key to imfinzi s apparent success. #gyncsm #cancerresearch #womenshealth #asco23 
Fierce #PatientAdvocate providing up to date research for 3K+ consumers @ risk & clinicians #JournalClub #bcsm #gyncsm #PancChat #BRCA #hereditarycancer